Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically...

Related Keywords

Scott Giacobello ,Marcy Graham ,Aadi Bioscience ,Company Annual Report On Form ,Nasdaq ,Prnewswire Aadi Bioscience Inc ,Linkedin ,Twitter ,Endometrial Cancer ,Neuroendocrine Tumors ,Recent Operational Highlights ,Investigator Initiated Trial ,Call Information ,Fast Track ,Looking Statements ,Private Securities Litigation Reform Act ,Mirati Therapeutics ,Annual Report ,Quarterly Reports ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Pharmaceuticals ,Otc ,Mallcap ,Earnings ,